The Application dimension of the Gastrointestinal Videoscopes market is divided into diagnostic, therapeutic and screening uses. Diagnostic procedures, such as routine colonoscopy and upper‑GI endoscopy, dominate the market because they generate the highest procedure volume and drive recurring equipment purchases, accounting for roughly 45 % of total revenue. Therapeutic applications—including polypectomy, hemostasis, and stent placement—require advanced imaging and accessory channels, contributing about 35 % of the market size as hospitals invest in higher‑cost, multifunctional scopes. Screening activities, primarily population‑level colorectal cancer programs, represent the remaining 20 % and are expanding in emerging economies where preventive health initiatives are gaining traction. Together, these application segments shape the overall Gastrointestinal Videoscopes segmentation, with each category’s growth rate reflecting procedural demand, reimbursement policies, and technology adoption across the healthcare continuum.